The hypothesis of helper T (T h )1 / T h 2 cytokine balance proposed by
INTRODUCTION
Until recently, Crohn ' s disease (CD) and ulcerative colitis (UC) had been regarded as mediated by interferon (IFN)--producing helper T (T h )1 cells and interleukin (IL)-4 / IL-13-producing T h 2 cells, respectively. 1 However, just after the discovery of T h 17 cells, which specifically produce T h 17 family cytokines, such as IL-17A, IL-17F, IL-21, and IL-22, many investigators reconsidered the T h 1 / T h 2 cytokine balance hypothesis, concluding that T h 17 cells are the instrumental T h cells involved in the pathogenesis of these diseases. 2, 3 Importantly, it has also been considered that each T h subpopulation is independently generated in the presence of specific cytokines via specific master transcription factors: T h 1 cells generate from na ï ve T cells in the presence of IL-12, and express T-bet (Tbx21); T h 2 cells generate in the presence of IL-4, and express GATA-3; and T h 17 cells generate in the presence of transforming growth factor (TGF)-plus IL-6, and express ROR t. 3 Development of experimental autoimmune encephalomyelitis had previously been thought to require IFN--producing T h 1 cells; however, in 2003 Cua et al. 4 found that IL-23 (an IL-12p35 / IL-23p19 heterodimer), rather than IL-12 (an IL-12p35 / p40 heterodimer) is essential for experimental autoimmune encephalomyelitis development. Thereafter, T h 17 cells (which produce IL-17A) were proposed as newly identified T helper cells that act independently of T h 1 and T h 2 cells. Subsequent studies showed that T h 17 cells mediate not only other murine models of autoimmune diseases and inflammatory bowel diseases (IBD), but also human autoimmune diseases and IBD. 5 -8 
T H 17 CELLS IN THE PATHOGENESIS OF HUMAN IBD
Before the discovery of T h 17 cells, Fujino et al. 9 reported that IL-17A expression is highly upregulated in CD3 + T cells and CD68 + macrophages in the inflamed mucosa of patients with IBD; similar reports followed. 10 -14 In addition, other T h 17-associated molecules, such as IL-17F, IL-21, IL-22, IL-23, ROR t, and IL-23R, are upregulated in inflamed mucosa of IBD patients. 15 -18 Rovedatti et al. 14 reported that not only mucosal IFN-+ IL-17A − T h 1 cells and IFN-− IL-17A + T h 17 cells but also IFN-+ IL-17A + T h 1 / T h 17 double-producing cells are highly expressed in the inflamed mucosa of UC and CD patients. Interestingly, they also showed that T h 1 / T h 17 cells resided particularly in the CD161 + subpopulation rather than in CD161 − cells. 14 Our group showed that IL-17A increases in the inflamed mucosa of UC patients, while IFN-increases in the inflamed mucosa of CD patients. 12 Although our analysis covered only CD patients, we found that both IFN-and IL-17A are upregulated in CD4 + T cells isolated from mesenteric lymph nodes. 19 In terms of T h 1 cells, however, most studies have shown normal IFN-levels in inflamed UC mucosa, although many studies offer evidence that IFN-expression is elevated in inflamed CD mucosa. 20 Therefore, it remains unknown whether T h 1 and T h 17 cells are dominant in the pathogenesis of IBD ROR t-dependent IL-17A-producing cells in the pathogenesis of intestinal inflammation REVIEW depending on the location, disease, and method used to assess cytokines.
We recently identified a unique CD14 + CD33 + CD205 + CD209 + macrophage, which specifically increases in the inflamed IBD mucosa, especially in CD, and produces large amounts of IL-23, IL-6, and tumor necrosis factor-. Of note, IL-23 promotes the production of IFN-and IL-17A by lamina propria (LP) mononuclear cells obtained from CD and UC tissues, respectively. 17 Subsequent analysis showed that increasing mucosal CD14 + macrophages in CD patients could induce IFN--producing T h 1 cells in vitro . 20 Although IL-23 potentially maintains or induces T h 17 cells, it has a critical role in inducing T h 1 cells in some specific immunological conditions. Consistent with this, genome-wide association studies have recently revealed that the gene IL-23R has a significant association with not only UC but also CD. 21, 22 
T H 17 CELLS IN PATHOGENESIS OF ANIMAL MODELS OF IBD
Research stimulated by a study of experimental autoimmune encephalomyelitis and murine T h 17 cells 4 has produced evidence of a significant role for T h 17 cells in the pathogenesis of animal IBD models ( Table 1 ) . Transgenic mice that ubiquitously expressed IL-23p19 spontaneously developed chronic enterocolitis; 23 colitis in IL-10-deficient mice was exacerbated by IL-23 administration; 24 and SCID mice in which IL-17A-producing T h 17 cells from C3Bir mice were transferred, spontaneously developed severe colitis, which was blocked by administration of anti-IL-23p19 monoclonal antibody (mAb). 25 Similarly, development of colitis in IL-10-deficient mice 24 and Helicobacter hepaticus ( Hh )-infected mice administered with anti-IL-10R mAb 26 was suppressed by anti-IL-23p19 mAb treatment. Irrespective of whether Hh -infected 26 or uninfected, 27 IL-23 − / − × RAG-1 − / − mice transferred with CD4 + CD45RB high T cells did not develop colitis. Furthermore, RAG-1 − / − mice transferred with CD4 + CD25 − T cells from ROR t − / − mice did not develop colitis. 28 However, one paper reported that 2,4,6-trinitrobenzene sulfonic acid-induced colitis was exacerbated in IL-23-deficient mice compared with wild-type (WT) mice. 29 In contrast, it is unsettled whether IL-17A has a pathological role in colitis. While IL-17R − / − mice developed less severe 2,4,6-trinitrobenzene sulfonic acid-induced colitis, 30 administering neutralizing anti-IL-17A mAb did not reduce severity of colitis in an adoptive transfer model of CD4 + CD45RB high T cells; however, coadministration of anti-IL-17A and anti-IL-6 significantly ameliorated the severity of intestinal inflammation. 24 Administration of anti-IL-17A mAb exacerbated dextran sulfate sodium-induced colitis, 31 while IL-17A − / − mice developed less severe dextran sulfate sodium-induced colitis. 32 There were no differences in colitis indices between RAG-1 − / − mice transferred with naive T cells from WT, IL-17A − / − , IL-17F − / − , or IL-22 − / − mice. 28 Interestingly, however, anti-IL-17A mAbtreated RAG-1 − / − mice transferred with naive T cells from IL-17F − / − mice developed significantly less severe colitis than did control mAb -treated RAG-1 − / − mice transferred with naive T cells from WT mice. 28 
INTERFERENCE BETWEEN COLITOGENIC T H 1 AND T H 17 CELLS
To investigate how colitogenic T h 1 and T h 17 cells collaborate or interfere with each other in the process of development of colitis in vivo , our group used two different colitis models: a T h 1-dominant adoptive transfer model, and a T h 1-and T h 17-mixed IL-10-deficient mouse model. We co-transferred the same number of CD4 + T cells isolated from colitic RAG-2 − / − mice transferred with CD4 + CD45RB high T cells and colitic IL-10 − / − mice, or mice transferred with one type alone, into new RAG-2 − / − mice. Interestingly, co-transferred mice developed colitis to an extent similar to mice transferred with one type of cells, and CD4 + T cells were well mixed in a ratio of approximately 1:1 in the inflamed colons of co-transferred mice. 35 However, the proportions of IFN--and IL-17A-expressing CD4 + T cells in co-transferred mice were significantly decreased compared with single-transferred mice, suggesting interference between colitogenic T h 1 and T h 17 cells in vivo . 35 Interestingly colitic RAG-2 − / − mice transferred with CD4 + CD45RB high T cells gradually became healthy, even after parabiosis surgery with colitic IL-10 − / − mice. The two types of CD4 + T cells were also well mixed in colonic LP, and the percentages of IFN--and IL-17A-expressing LP CD4 + T cells tended to decrease after parabiosis surgery, which is one reason for the amelioration of colitis. 33 All these experiments indicate that disease phenotypes of colitis grossly depend on REVIEW a balance of cytokine interference, including the competition between T h 1 and T h 17 cells.
LINEAR DEVELOPMENTAL PATHWAY FROM T H 17 TO T H 1 CELLS IN THE DEVELOPMENT OF COLITIS
In the current immunology, the new T h cell subsets, such as IL-10-producing Tr1 cells, 36 follicular helper T cells, which support antibody-producing B cells, 37 IL-9-producing Th9 cells, 38 and IL-22-producing T h 22 cells, 39 are emerging besides T h 1, T h 2, T h 17, and CD4 + CD25 + Foxp3 + T regulatory (T reg ) cells, 40 and the plasticity between those cells is also now extensively under investigation. 7 Initially, it was thought that T h 1 and T h 17 cells are generated from naive CD4 + T cells independently, and that terminally differentiated T h cells seldom re-differentiate to other T h subsets. Following the discovery of induced pluripotent stem cells, 41 which are reprogrammed from terminally differentiated cells, it became evident that many types of cells can re-differentiate to others; e.g., even protective T reg cells can re-differentiate to pathogenic T h 1, T h 17, and follicular helper T cells. 42 Against this background, Weaver ' s group recently reported that T h 1 cells are generated from IL-17F-expressing T h 17 cells in the late stages of colitis development. 43 They first showed that IL-17F reporter mice-derived IL-17F + (green fluorescent protein, GFP + ) IFN-− T h 17 cells generated in the presence of TGF-and IL-6 converted to IL-17A − / IFN-+ " T h 1-like " cells in the absence of TGF-and in the presence of IL-23. Then, the in vitro -manipulated IL-17F + CD4 + T h 17 cells were transferred into RAG-1 − / − mice. In this setting, mice not only deve loped colitis but also retained IL-17A − IFN-+ T h 1-like cells in the inflamed mucosa, indicating that committed T h 17 cells give rise to progeny that lost IL-17A expression and upregulated IFN-expression in the late stage of colitis development. Although these findings explain why both T h 1 and T h 17 cells are
Table 1 Role of T h 17 cells in murine models of IBD

Pathogenic role of IL-23
Wiekowski et al. 23 IL-23p19 transgenic mice spontaneously develop enterocolitis Kullberg et al. 26 No colitis in Hh -infected RAG-1 − / − × IL-23 − / − mice transferred with CD4 + CD45RB high T cells
Anti-IL-23 mAb suppresses colitis in anti-IL-10R-treated Hh-infected mice
Yen et al. 24 IL-23 administration exacerbates colitis in IL-10 − / − mice, while anti-IL-23 mAb administration suppresses colitis in those mice
Elson et al. 25 Anti-IL-23 mAb treatment suppresses the development of colitis in RAG-1 − / − mice transferred with T h 17 cells from colitic C3Bir mice
Izcue et al. 27 No colitis in RAG-1 − / − x IL-23 − / − mice transferred with CD4 + CD45RB high T cells
Protective role of IL-23
Becker et al. 29 Severer TNBS-induced colitis in IL-23 − / − mice
Pathogenic role of ROR t
Leppkes et al. 28 No colitis in RAG-1 − / − mice transferred with ROR t − / − CD4 + CD25 − T cells
Pathogenic role of IL-17A
Zhang et al. 30 Milder TNBS-induced colitis in IL-17R − / − mice Ito et al. 32 Milder DSS-induced colitis in IL-17A − / − mice
Non-effective role of IL-17A
Izcue et al. 27 No change of colitis in RAG-1 − / − mice transferred with IL-17A − / − CD4 + CD45RB high T cells
Leppkes et al. 28 Anti-IL-17A treatment does not affect colitis in RAG-1 − / − mice transferred with CD4 + CD25 − T cells
Yen et al. 24 Anti-IL-17A treatment does not affect colitis in RAG-1 − / − mice transferred with CD4 + CD45RB high T cells (coadministration of anti-IL-17A and anti-IL-6 mAbs ameliorates colitis)
Protective role of IL-17A
Ogawa et al. 31 Anti-IL-17A administration exacerbates DSS-induced colitis O ' Connor et al. 33 Exacerbation of colitis in RAG-1 − / − mice transferred with IL-17A − / − or IL17R − / − CD4 + CD45RB high T cells 44 We noticed that IL-17A + IFN-+ T h 17 / T h 1 cells reside in only the inflamed mucosa of this model, but not in normal mucosa of WT mice. When RAG-2 − / − mice were transferred with CD4 + CD45RB high T cells derived from ROR t -GFP reporter mice, we first confirmed that they developed colitis, but only ~ 10 % of CD3 + CD4 + T cells were GFP + (ROR t + ), suggesting that this model would be T h 1 dominant as whole CD3 + CD4 + T cells were CD44 high CD62L − IL-7R high effector-memory T cells. Thereafter, GFP + (ROR t + ) or GFP − (ROR t − ) CD4 + T cells were isolated from inflamed mucosa of those mice using a fluorescence-activated cell sorter. To further assess the roles of GFP − and GFP + cells in terms of colitogenecity, these cells were again transferred into new RAG-2 − / − mice. In both cases, the re-transferred mice developed colitis to a similar extent. When the expression of GFP was examined after re-transfer, we found that LP CD4 + T cells isolated from mice transferred with GFP − cells remained GFPnegative and preferentially produced IFN-, but not IL-17A, suggesting that re-differentiation from T h 1 ; Is this linear developmental pathway from T h 17 to T h 1 cells the only one to mediate colitis? On the basis of the independent developmental pathway of T h 1 and T h 17 cells, it is likely that RAG-1 − / − mice transferred with naive T cells from T-bet − / − or ROR t − / − mice can develop T h 17-or T h 1-mediated colitis, respectively. In this regard, however, RAG-1 − / − mice transferred with naive T cells from T-bet − / − or ROR t − / − mice reportedly did not develop colitis at all. 28, 47 This discrepancy suggests that the linear developmental pathway is essential for colitis development. We called colitogenic T h 1 cells that arise from T h 17 cells via such a linear pathway " alternative " T h 1 cells; they may be genuinely pathological T h 1 cells in colitis development. Interestingly, this hypothesis allows that the adoptive transfer model of colitis depends more on IL-23 than IL-12. 26 Further study is needed to determine whether classical T h 1 cells generated in ROR t-independent manner are truly involved in colitis development.
T REG CELLS BLOCK THE DEVELOPMENTAL PATHWAY FROM T H 17 TO T H 1 CELLS
The next question arising is how CD4 + CD25 + Foxp3 + T reg cells affect the linear developmental pathway from T h 17 to 45 indicating that T reg cells suppress not only the pathway between T h 17 / T h 1 and T h 1 cells, but also the induction of Tbx21 in colitogenic effector-memory T cells ( Figure 1 ). Furthermore, consistent with the results of Weaver ' s study showing that this transformation from T h 17 to T h 1 cells occurs in the absence of TGF-and increases in mice treated with anti-IL-23R, 43 it is possible that TGF-derived from T reg cells suppresses the development from T h 1, T h 17 / T h 1 to alternative T h 1 cells. Another possible mechanism of action of T reg cells is shown in Chen and colleagues ' recent demonstration that IL-2 consumption by IL-2R (CD25)-expressing T reg cells increases T h 17 cell development in Foxp3.luciDTR mice, in which diphtheria toxin selectively depletes Foxp3 + T reg cells. 48 Pandiyan and colleagues reported a similar result. 49 In this regard, these two papers may explain the previous finding that IL-2 suppresses the development of T h 17 cells. 50 
ROR T-DEPENDENT INNATE LYMPHOID CELLS IN ANIMAL MODELS OF IBD PATHOGENESIS
Besides T h 17 lymphocytes, immune cells, such as natural killer (NK) cells, NKT cells, TCR -expressing T cells, macrophages, and Paneth cells, can produce IL-17A. 51 Of parti cular importance, these more innate immune cells, unlike T h 17 cells, immediately secrete IL-17A in response to specific alert molecules such as pathogen-associated molecular patterns and cytokines such as IL-23. However, the involvement of these " non-Th17 cell IL-17A-producing cells " to colitis pathogenesis is not fully understood and are now an area of intense research. Furthermore, evidence is emerging of a new IL-17A-producing cell population, innate lymphoid cells (ILCs), that have crucial roles in not only the formation and maintenance of gut-associated lymphoid tissue (GALT), but also colitis pathogenesis in animals and humans. 52 There are various kinds of ILCs categorized by location, cytokine production, and expression of specific surface markers and intracellular transcription factors, including lymphoid tissue inducer (LTi) cells, which are involved in GALT formation during the fetal period. Similar LTi cells are also present in the gut and tonsils after birth, and are called adult LTi-like (hereafter described as LTi-like) cells. 53 These cells may have important roles in the generation of cryptopatches and isolated lymphoid follicles, and in the maintenance of all GALT after birth, but experimental proof for the role of LTi-like cells after birth is lacking. The LTi / LTi-like cells constitutively express ROR t; consistently ROR t − / − mice completely lack GALT. Therefore, ROR t is a master transcription factor for not only T h 17 cells, but also LTi / LTi-like cells. These cells also promptly produce IL-17A in response to IL-23, which may be induced in activated antigen-presenting cells such as macrophages and dendritic cells. Although it is known that LTi cells produce both IL-17A and IL-22, several groups have identified NK receptor (NKR)-expressing " LTi-like " -like cells that express ROR t and produce IL-22 but not IL-17A in the tonsils and intestines. These cells are now designated (not uniformly) as NK22, NKR-LTi, NCR-22, NKR + ROR t + ILC, and ILC22 cells. These cells specifically express NKp46 but not NKp44 in mice, and in contrast, NKp44 but not NKp46 in humans. 54, 55 Importantly, IL-22 is a IL-10 family cytokine, but its specific receptor seems to be expressed only on non-hematopoietic cells, such as epithelial cells, whereas IL-10R is specifically expressed on hematopoietic cells. Consistent with this, IL-22 − / − mice and ROR t − / − mice develop more severe colitis with marked epithelial damage in the dextran sulfate sodium-induced colitis model than do control WT mice, 55, 56 and IL-22 − / − mice develop more severe intestinal epithelial damage in the Citrobacter infection colitis model, 57 suggesting that ILC22 (NK22) cells are critical to epithelial repair ( Figure 2 ). However, it remains unclear whether ILC22 cells develop from LTi / LTi-like cells 55 or directly from ROR t + ILC precursor cells 58 that have not yet been identified. Nevertheless, it seems that LTi / LTi-like cells preferentially reside in GALT and have important roles in generating and maintaining GALT, while ILC22 cells diversely reside in intestinal LP to promote epithelial repair.
The next critical issue is whether ILC cells are pathologically involved in IBD development. In this regard, Powrie ' s group first described pathological ILC cells in two models of innate colitis ( Figure 2 ) . 59 In the first model of Hh -infected RAG-1 − / − mice, the proportion and absolute number of unique Thy1 high Sca-1 + ILC cells that produce not only IL-17A and IL-22 but also IFN-(ILC17 or ILC17 / 1 cells) were markedly increased in the colonic LP. Like physiological-condition LTi / LTi-like cells, ILC cells in colitic Hh -infected RAG-1 − / − mice are Lin (CD11b, Gr1, B220) − ROR t + NKp46 − IL-7R + CCR6 + , but unlike LTi / LTi-like cells, they are Sca-1 + c-kit − CD4 − . It is not known whether those pathological ILC cells are derived from physiological-condition LTi / LTi-like cells or are generated from ROR t + ILC precursor cells ( Figure 2 ). Administration of anti-Thy1 mAb to target those Thy1 high Sca-1 + ILC cells suppressed the development of Hhinduced innate colitis in RAG-1 − / − mice, although it is unclear if anti-Thy1 treatment targets only the pathological ILC cells in this model, as Thy1 is broadly expressed on various cells (such as NK cells). Of note, pathological ILC cells expressed T-bet and ROR t, suggesting that they are counterparts of REVIEW IL-17A / IFN--double -producing T-bet + ROR t + T h 1 / T h 17 cells. This group attempted using another innate colitis model, 58 in which RAG-1 − / − mice are administered anti-CD40 mAb to activate antigen-presenting cells. In this second model, increased Thy1 high Sca-1 + ILC cells also emerged in inflamed colon mucosa, and anti-Thy1 mAb treatment blocked the development of colitis. Interestingly, unlike the model of Hh -infected RAG-1 − / − mice, these ILC cells produced IFN-and IL-22, but not IL-17A, although they expressed ROR t. Therefore, this second type of ILC cells (possibly ILC1) that emerged in anti-CD40-administerred mice is not identical to the ILC17 or ILC17 / 1 in Hh -infected RAG-1 − / − mice. Furthermore, ROR t − / − × RAG-1 − / − mice were totally resistant to this anti-CD40 mAb administration model, suggesting that ROR t is essential for the generation or maintenance of the second type of pathological ILC1 cells; i.e., ILC cells are essential for colitis development, following the activation of antigen-presenting cells via CD40 molecules to produce IL-23. Further studies should address the developmental pathway and plasticity of colitogenic ILC cells, their relationship to T-bet, the reason those two colitogenic ILC cells produce IL-22, and the distinct location of those cells.
Subsequently, Diefenbach ' s group elegantly showed a sequential developmental pathway for LTi-like cells ; ROR t + NKR -ILC (NKp46 + ) ; IFN--producing ROR t − NKR -ILC (NKp46 + ) in the process of anti-CD40 mAb-induced innate colitis, using ROR t fate-map mice. 55 These colitogenic IFN--producing ROR t − NKR -ILC cells differ from conventional NK (cNK) cells, as they could be depleted by anti-NK1.1 mAb, but not by anti-asialo GM1 mAb, while cNK cells were depleted by either anti-NK1.1 mAb or anti-asialo GM1 mAb. Consistent with this, administration of anti-NK1.1 mAb, but not anti-asialo GM1, ameliorated this colitis model. 54 60 -62 The natural helper cells reside in adipose tissue in the peritoneal cavity as " fat-associated lymphoid clusters " , and are as dependent on common gamma ( c) receptors as LTi / LTi-like cells are, but -unlike LTi / LTi-like cells -are independent of ROR t, indicating that ILC2 subsets are generated from hematopoietic precursor cells in an ROR t-independent manner. However, it is unclear whether this new ILC2 subset is involved in the pathogenesis of human IBD and their animal models. The natural helper cells in fat-associated lymphoid cluster in the mesentery may have a pathological role in forming mesenteric fat lapping -a particular finding in CD. Interestingly, nuocytes 61 and Ih2 cells 62 Much new evidence about IL-17A-producing immune cells will likely soon emerge. We can be cautiously optimistic that these new findings will solve many puzzles of IBD pathogenesis, and generate novel therapeutic strategies for these diseases. 63 However, whether LTi-like cells and ILC22 cells are increased or decreased in inflamed IBD mucosa is still debatable; 63, 64 and the origin of mNK cells is still undetermined. CD, Crohn ' s disease; ILC, innate lymphoid cells; LTi, lymphoid tissue inducer; UC, ulcerative colitis.
